BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/5/2023 3:12:10 AM | Browse: 241 | Download: 841
 |
Received |
|
2022-10-16 08:40 |
|
Peer-Review Started |
|
2022-10-16 08:42 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2022-11-04 08:27 |
|
Revised |
|
2022-11-10 12:17 |
|
Second Decision |
|
2022-12-16 03:35 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2022-12-16 10:00 |
|
Articles in Press |
|
2022-12-16 10:00 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-12-26 05:48 |
|
Publish the Manuscript Online |
|
2023-01-05 03:12 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Case Report |
| Article Title |
Pembrolizumab-induced psoriatic arthritis treated with disease-modifying anti-rheumatic drugs in a patient with gastric cancer: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Sehan Kim, Jong Hee Sun, Hongsik Kim, Hee Kyung Kim, Yaewon Yang, Jun Su Lee, In Ah Choi and Hye Sook Han |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Hye Sook Han, MD, Professor, Department of Internal Medicine, Chungbuk National University Hospital, Chungbuk National University College of Medicine, 1 Chungdae-ro, Seowon-gu, Cheongju 28644, South Korea. hyesukhan@chungbuk.ac.kr |
| Key Words |
Pembrolizumab; Psoriatic arthritis; Disease-modifying anti-rheumatic drugs; Gastric cancer; Case report |
| Core Tip |
Although immune checkpoint inhibitors are being used increasingly and widely, a fair percentage of patients treated with these drugs experience immune-related adverse events (irAEs). Arthralgia and skin lesions are among the most frequent irAEs. However, rheumatic irAEs are underreported and/or misclassified and have been poorly characterized. These rheumatic irAEs are different in simple arthralgia or cutaneous irAEs that they may be requiring long-term management and disease-modifying anti-rheumatic drugs in severe or refractory case. We report a first case of pembrolizumab-induced psoriatic arthritis that was treated with tumor necrosis factor-α inhibitors in a patient with gastric cancer and discuss the treatment course. |
| Publish Date |
2023-01-05 03:12 |
| Citation |
Kim S, Sun JH, Kim H, Kim HK, Yang Y, Lee JS, Choi IA, Han HS. Pembrolizumab-induced psoriatic arthritis treated with disease-modifying anti-rheumatic drugs in a patient with gastric cancer: A case report. World J Clin Cases 2023; 11(1): 218-224 |
| URL |
https://www.wjgnet.com/2307-8960/full/v11/i1/218.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v11.i1.218 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
